| Date Filed | Type | Description |
| 11/15/2016 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB |
| 08/15/2016 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB |
| 04/28/2016 |
8-K/A
| Quarterly results |
| 04/06/2016 |
8-K
| Form 8-K - Current report |
| 01/11/2016 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 2.8% stake in Skystar Bio-Pharmaceutical Company |
| 06/02/2015 |
SC 13D/A
| SJ STRATEGIC INVESTMENTS LLC reports a 14.2% stake in Skystar Bio-Pharmaceutical Company |
| 02/04/2015 |
SC 13D/A
| SJ STRATEGIC INVESTMENTS LLC reports a 12.4% stake in Skystar Bio-Pharmaceutical Company |
| 01/12/2015 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 6.5% stake in Skystar Bio-Pharmaceutical Company |
| 12/15/2014 |
SC 13D/A
| GREGORY JOHN M reports a 11.2% stake in SKYSTAR BIO-PHARMACEUTICAL CO |
| 11/14/2014 |
10-Q
| Quarterly Report for the period ended September 30, 2014 |
| 11/13/2014 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 08/14/2014 |
10-Q
| Quarterly Report for the period ended June 30, 2014 |
| 07/17/2014 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 10% stake in Skystar Bio-Pharmaceutical Company |
| 07/16/2014 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 05/28/2014 |
SC 13D/A
| SJ STRATEGIC INVESTMENTS LLC reports a 10% stake in Skystar Bio-Pharmaceutical Company |
| 05/15/2014 |
10-Q
| Quarterly Report for the period ended March 31, 2014 |
| 04/15/2014 |
SC 13D/A
| SJ STRATEGIC INVESTMENTS LLC reports a 8.7% stake in Skystar Bio-Pharmaceutical Company |
| 04/02/2014 |
SC 13D/A
| SJ STRATEGIC INVESTMENTS LLC reports a 7% stake in Skystar Bio-Pharmaceutical Company |
| 03/31/2014 |
10-K
| Annual Report for the period ended December 31, 2013 |
| 03/24/2014 |
SC 13D
| SJ STRATEGIC INVESTMENTS LLC reports a 3.8% stake in Skystar Bio-Pharmaceutical Company |
| 12/04/2013 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933 |
| 11/14/2013 |
10-Q
| Quarterly Report for the period ended September 30, 2013 |
| 10/30/2013 |
8-K
| Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits |
| 09/27/2013 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements |
| 09/24/2013 |
SC 13G/A
| RENN Universal Growth Investment Trust reports a 4.9% stake in 8 Skystar Bio-Pharmaceutical Company |
| 09/23/2013 |
SC 13G/A
| RENN Universal Growth Investment Trust reports a 5.1% stake in 7 Skystar Bio-Pharmaceutical Company |
| 09/13/2013 |
SC 13G/A
| RENN Universal Growth Investment Trust reports a 6.2% stake in 6 Skystar Bio-Pharmaceutical Company |
| 09/04/2013 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/22/2013 |
SC 13G/A
| RENN Universal Growth Investment Trust reports a 7.4% stake in 4 Skystar Bio-Pharmaceutical Company |
| 08/14/2013 |
10-Q
| Quarterly Report for the period ended June 30, 2013 |
| 05/15/2013 |
10-Q
| Quarterly Report for the period ended March 31, 2013 |
| 04/01/2013 |
10-K
| Annual Report for the period ended December 31, 2012 |
| 11/14/2012 |
10-Q
| Quarterly Report for the period ended September 30, 2012 |
| 10/26/2012 |
8-K
| Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits |
|